DiCE Antibody Charge Variant Analysis via Enzymatic Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for accurately and efficiently characterizing the biophysical properties and domain-specific variants of therapeutic peptides and proteins, such as antibodies, which affects their safety, efficacy, and shelf-life due to heterogeneity caused by post-translation modifications and protein degradation.
Innovation Solution
The use of digestion-assisted imaged capillary electrophoresis (DiCE) methods, including isoelectric focusing, to identify and quantify charge variants within therapeutic peptides or proteins, specifically employing enzymes like IdeS to generate fragments and separate them based on charge heterogeneity, molecular weight, or combinations thereof.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional characterization methods are used, then the analysis can be performed with standard equipment, but the accuracy and sensitivity in detecting domain-specific charge variants is insufficient
Solution Approach 1:
The antibody molecule is divided into separate domains (Fc and Fab regions) through enzymatic digestion with IdeS. This segmentation allows each domain to be independently analyzed for charge variants, significantly improving detection accuracy and sensitivity compared to analyzing the intact antibody as a single unit.
Solution Approach 2:
Digestion enzymes (IdeS, papain, pepsin) serve as intermediaries to break down the antibody into domain-specific fragments. These enzymes enable selective access to particular regions of the antibody, allowing precise characterization of charge variants in specific domains without requiring direct manipulation of the intact complex structure.
2Loss of information
If intact antibody analysis is performed, then the overall charge distribution can be measured, but domain-specific charge variants cannot be distinguished
Solution Approach 1:
By digesting the antibody into domain-specific fragments using enzymes like IdeS (which cleaves the Fc region), papain (which produces Fab fragments), or pepsin (which produces F(ab')2 fragments), the method preserves domain-specific information that would be lost in intact antibody analysis. Each domain can then be independently characterized for charge variants.
Solution Approach 2:
The method applies different analytical conditions to different domains of the antibody. Each domain fragment is analyzed separately, allowing local quality assessment of charge variants in specific regions (Fc, Fab, light chains) rather than averaging across the entire molecule, thus preventing information loss about domain-specific modifications.
3Reliability
If multiple PTMs and modifications are analyzed simultaneously, then comprehensive characterization is achieved, but the complexity of data interpretation increases
Solution Approach 1:
The antibody is segmented into domains that can be independently analyzed for different types of post-translational modifications. This segmentation allows simultaneous analysis of multiple PTMs (glycosylation, oxidation, deamidation, C-terminal lysine variants) in different domains without overwhelming complexity, as each domain can be characterized separately and then integrated into a comprehensive quality assessment.
Solution Approach 2:
The electrophoresis-based separation method serves multiple functions: it separates domain fragments by charge, detects various types of PTMs simultaneously, and provides quantitative data on modification levels. This multi-functionality enables comprehensive characterization of multiple modifications without requiring separate specialized assays for each type of PTM.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a sensitive and accurate method for detecting and quantifying domain-specific charge variants, enhancing the characterization of therapeutic proteins, ensuring product quality and stability by distinguishing individual domains within bispecific antibodies and other protein modalities.
Implementation Method 1
treating the at least one peptide or protein with one or more digestion enzymes to generate components of the at least one peptide or protein
Implementation Method 2
reducing or denaturing the components of the at least one peptide or protein
Implementation Method 3
separating two or more components of the at least one peptide or protein based on charge variants of the components
Implementation Method 4
digestion-assisted imaged capillary electrophoresis (DiCE) methods
Data Source
AI summary
The present invention provides methods and systems for analyzing the biophysical characteristics of peptides or proteins, such as antibodies, based on enzymatic digestion-assisted imaged capillary electrophoresis (DiCE) to characterize the domain-specific charge variants, preferably within a bispecific antibody. The methods and systems include treating the protein with digestion enzymes to generate components of the protein, reducing or denaturing the components, and separating the components based on their isoelectric points.